| Log in
Chandru Chawla

Consolidation has been slow in Indian healthcare: Cipla’s Chandru Chawla

10 October, 2016

Indian drugmaker Cipla revived its inorganic expansion strategy in 2013 and has been pursuing acquisitions at a frenetic pace since then. The firm has announced acquisition deals w ....

To read the Full Story

Covering India’s Investment Ecosystem

subscribe

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
Cipla generates four-fold returns from Chase Pharma stake sale

Cipla generates four-fold returns from Chase Pharma stake sale

Joseph Rai 10 months ago
Drugmaker Cipla Ltd has sold its entire stake in the US-based Chase...
Cipla to lead $21M investment in US-based Chase Pharma

Cipla to lead $21M investment in US-based Chase Pharma

Lohit Jagwani 3 years ago
Mumbai-based drug major Cipla Limited has invested $1.5 million in US-based drug...
Exclusive: Cipla BioTec hires banker for biggest PE fundraise in biosimilar space

Exclusive: Cipla BioTec hires banker for biggest PE fundraise in biosimilar space

Ranjani R 1 year ago
Cipla BioTec Pvt Ltd, the bio-similar firm incubated by pharmaceuticals giant...
No Comments

Consolidation has been slow in Indian healthcare: Cipla’s Chandru Chawla

Powered by WordPress.com VIP